2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone

Star0

DB03009ExperimentalSmall molecule

2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone: Overview.

Formula / weight: C₁₂H₁₄F₃N₃O₂S · 321.319 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL360376PubChem448768

Structure

InChIKeyUDBHGUOSOKOIAX-UHFFFAOYSA-NSMILES[H]N1C(SCC(=O)N2CCCCC2)=NC(=O)C=C1C(F)(F)F

What you can answer from here — as of August 31, 2026

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of 2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account